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ABSTRACT Two subunits of influenza hemagglutinin (HA), HA1 and HA2, represent one of the best-characterized mem-
brane fusion machines. While a low pH conformation of HA2 mediates the actual fusion, HA1 establishes a specific
connection between the viral and cell membranes via binding to the sialic acid-containing receptors. Here we propose that
HA1 may also be involved in modulating the kinetics of HA refolding. We hypothesized that binding of the HA1 subunit to its
receptor restricts the major refolding of the low pH-activated HA to a fusion-competent conformation and, in the absence of
fusion, to an HA-inactivated state. Dissociation of the HA1-receptor connection was considered to be a slow kinetic step. To
verify this hypothesis, we first analyzed a simple kinetic scheme accounting for the stages of dissociation of the HA1/receptor
bonds, inactivation and fusion, and formulated experimentally testable predictions. Second, we verified these predictions by
measuring the extent of fusion between HA-expressing cells and red blood cells. Three experimental approaches based on
1) the temporal inhibition of fusion by lysophosphatidylcholine, 2) rapid dissociation of the HA1-receptor connections by
neuraminidase treatment, and 3) substitution of membrane-anchored receptors by a water-soluble sialyllactose all provided
support for the proposed role of the release of HA1-receptor connections. Possible biological implications of this stage in HA
refolding and membrane fusion are being discussed.
INTRODUCTION
Influenza virus enters the host cell by receptor-mediated
endocytosis followed by fusion of the viral envelope with
the endosomal membrane. This fusion reaction, a paradigm
of ubiquitous biological membrane fusion, is mediated by
the homotrimeric envelope glycoprotein hemagglutinin
(HA) (White, 1996). In the fusion-competent form each of
the HA monomers contains two disulfide-bonded polypep-
tide subunits, HA1 and HA2. Acidification of the endosome
triggers a major conformational change in HA, which is
associated with membrane fusion. This refolding involves
release of the amphiphilic amino-terminal peptide of HA2
(“fusion peptide”) and its insertion into membranes (Gaudin
et al., 1995). Low pH application also causes extension and
reorientation of the central coiled coil core of HA2 (Bul-
lough et al., 1994; Carr and Kim, 1993; Chen et al., 1999;
Weissenhorn et al., 1997) and relocation of the globular
HA1 subunits from their initial position at the top of the
central fibrous stem of HA, which is composed largely of
HA2 (Godley et al., 1992; Kemble et al., 1992; White and
Wilson, 1987; Wiley and Skehel, 1987).
According to a common view, the two subunits of HA
perform distinct tasks in the fusion process. The HA2 sub-
unit is required and sufficient for fusion per se (Wiley and
Skehel, 1987), whereas HA1 plays an accessory role pro-
viding virus binding to the host cell via sialic acid-contain-
ing receptors (Wiley and Skehel, 1987). In the present study
we show that involvement of HA1 subunit in the fusion
reaction goes beyond the binding mechanism.
This work was initially motivated by studies on HA
inactivation with respect to fusion. Low pH application in
the absence of an appropriate membrane contact (Puri et al.,
1990) or in the presence of lysophosphatidylcholine (LPC)
(Chernomordik et al., 1997) leads to the loss of HA’s ability
to mediate fusion. Moreover, such low pH pretreatment
results in a profound inhibition of fusion observed after the
application of an additional low pH pulse in conditions
already favorable for fusion (Gutman et al., 1993; Junankar
and Cherry, 1986; Puri et al., 1990; Ramalho-Santos et al.,
1993; White et al., 1982). The presence of the target mem-
brane during low pH application dramatically slows down
this inactivation (Alford et al., 1994; Chernomordik et al.,
1997, 1998; Ramalho-Santos et al., 1993; Schoch et al.,
1992). We hypothesized that this inhibition of HA inacti-
vation in the presence of the target membrane reflects the
effect of the HA1-receptor interaction.
The current knowledge of the involvement of HA1 and its
receptor in fusion remains fragmentary. It has been demon-
strated that specific interaction of HA1 with sialic acid is
not a prerequisite for fusion. HA-expressing membranes
(HA membranes) readily fuse with bound membranes lack-
ing receptors (Schoen et al., 1996; White et al., 1982),
although the kinetics of fusion can differ from that in the
presence of receptors (Alford et al., 1994; de Lima et al.,
1995; Niles and Cohen, 1993; Stegmann et al., 1995).
Furthermore, the HA1-sialic acid connection is not required
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for fusion completion at low pH-independent stages of
fusion subsequent to low pH triggering (Chernomordik et
al., 1997, 1998; Schoch et al., 1992).
While HA refolding leading to fusion could occur in the
absence of HA1-sialic acid binding, this binding and the
HA1 subunit itself could modulate the refolding. HA1 was
hypothesized to lock HA2 in a metastable conformation
before low pH activation (Carr et al., 1997; Carr and Kim,
1993; Chen et al., 1995; Kim et al., 1996). Tilting of the
HA2 subunit at low pH, which is apparently involved in
HA-mediated fusion (Tatulian et al., 1995), was recently
found to require the presence of the HA1 subunit (Gray and
Tamm, 1998). The HA1-sialic acid connection can promote
refolding of HA toward its fusion-competent conformation
(de Lima et al., 1995; Stegmann et al., 1995). On the other
hand, based on the decrease in the fusion rates observed for
higher surface density of receptors, Alford et al. (1994)
hypothesized that HA molecules bound to sialic acids are
incapable of mediating fusion (Alford et al., 1994). Inter-
estingly, HA molecules bound to surrogate receptors (anti-
HA antibodies) can mediate fusion (Millar et al., 1999).
In the present work we studied the effect of HA1-receptor
binding on the fusion reaction downstream of establishing
membrane contact. We hypothesized that the HA1-sialic
acid connections slow down refolding of the low pH-acti-
vated HA. To test this hypothesis we first analyzed theo-
retically the kinetics of HA refolding and the related fusion
reaction by considering dissociation of the HA1-receptor
connections as a slow stage of the protein rearrangements
leading to fusion. Second, the predictions of this hypothesis
were verified experimentally for HA inactivation and fusion
of HA-expressing cells (HA cells) to human red blood cells
(RBCs).
THE MODEL
Amount of HA molecules bound to their
receptors before low pH application
First, let us demonstrate that after establishing contact be-
tween an HA membrane and a target membrane containing
the sialic acid receptors, most of the HA molecules are
bound to receptors.
This binding can be described in the familiar terms of a
dynamic equilibrium between association and dissociation
of the HA-receptor complexes. Note that in our system two
kinds of molecules undergoing binding are located in the
opposing membranes, where they can move by lateral dif-
fusion. Hence the HA-receptor binding can be seen as a
chemical reaction in a two-dimensional solution of the
reacting substances, where the lipid molecules constituting
the membranes play the role of a solvent. Thus it is conve-
nient to describe the system by referring to the surface
concentrations of the reacting substances, denoted by
CHA-R, CHA, and CR, for the HA-receptor complexes, the
unbound HA molecules, and the unbound receptors, respec-
tively. The equation expressing the dynamic equilibrium is
CHACR KCHA-R (1)
where K is the dissociation constant of the HA-receptor
complexes. Provided that the total surface concentrations of
the HA and receptor molecules are CHA,t and CR,t, respec-
tively, Eq. 1 determines the concentration of the complexes:
CHA,t CHA-RCR,t CHA-R KCHA-R (2)
The degree of binding is determined by the ratio between
the total surface concentrations CHA,t and CR,t of the HA
and receptor molecules, and the dissociation constant K.
The total surface concentration of the HA molecules in an
HA cell, CHA,t, estimated for HAb2 cells, for instance, is
2500 m2 (Danieli et al., 1996). This is10 times lower
than the HA concentration in the envelope of the influenza
virus. The number of sialic acid-containing receptors in one
RBC is 106, which corresponds to a surface density of
CR,t  8000 m
2. Liposomes containing 1 mol% of gan-
gliosides can have an even higher surface density of recep-
tors. To estimate the dissociation constant K, we assumed
that the energy of interaction between the HA1 subunit of
membrane-anchored HA and the membrane receptor is
equal to the energy of interaction between the sialic acid-
containing molecules and the soluble extracellular domains
of HA in the bulk aqueous solution (Sauter et al., 1992b).
The dissociation constant Kd  3 mM of the sialic acid-HA
ectodomain complexes measured for sialyllactose by Sauter
et al. (1992b) can be related to the energy of formation of
one complex, , by Kd  Wexp(/kT), where W  55 M is
the concentration of water molecules. The dissociation con-
stant K determining the HA-receptor binding in the mem-
brane system (Eqs. 1 and 2) can be represented as K 
Clexp(/kT), where Cl  1.7  10
6 m2 is the surface
concentration of the lipid molecules. Hence K is given by
K  KdCl/W and can be estimated as K  100 m
2. This
value is more than 10 times lower than the total surface
concentrations CHA,t and CR,t of the HA and receptor mol-
ecules. Solving Eq. 2 with the proposed values for K, CHA,t,
and CR,t gives 98% of all HA molecules in the contact
region as being involved in HA-receptor complexes. Even if
because of some steric hindrance only 1 of 10 receptors is
accessible for an HA binding site, 60% of HA molecules
in the contact region are expected to be receptor-bound.
Sequence of events downstream of
low pH application
The above estimate shows that the majority of HA mole-
cules in the contact region are bound to the receptors before
low pH activation. We suggest that this binding constrains
the low pH-triggered refolding of the HA2 subunits neces-
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sary for fusion. Consequently, to undergo the refolding HA
molecules have to first break the HA1-receptor connections.
Low pH-triggered conformational change of a receptor-
bound HA molecule is hypothesized to proceed through the
following states:
In the first state, the “activated-locked” conformation, the
initial conformational change of the HA2 subunit (i.e., ex-
posure of the fusion peptide), has already taken place.
Nonetheless, the subsequent major refolding is still re-
stricted by HA1-receptor interaction.
Next, the tendency to undergo further refolding produces
an effective stress inside each HA molecule. This stress
results in the breakdown of the HA1-receptor bond and
consequent transition of the HA molecule into the second,
“activated-unlocked” conformation. In this state HA medi-
ates membrane fusion with a certain probability.
Final structural changes in the HA molecule proceed
from the activated-unlocked state into an “inactivated” state
that is incapable of inducing membrane fusion. This inac-
tivation may correspond to the completion of the coiled coil
extension and reorientation of parts of HA2 (Bullough et al.,
1994) and related relaxation of the membrane stresses and
smoothing out of the fusion dimple (Kozlov and Cherno-
mordik, 1998). Alternatively, it may reflect aggregation of
fusion peptides of adjacent low pH-activated HA molecules
and the irreversible insertion of fusion peptides into HA
membrane. For the present study the specific nature of the
inactivated configuration is not crucial.
Kinetic scheme and equations
A sophisticated kinetic model of HA multimerization and
activation was presented by Bentz (1999). For the qualita-
tive purpose of the present work we analyzed a simplified
kinetic scheme (illustrated in Fig. 1 A) that corresponds to
the sequence of the above-discussed states. Three boxes
depict 1) the activated-locked, 2) activated-unlocked, and 3)
inactivated configurations of the HA molecules. The arrows
between these configurations indicate the pathway of the
HA evolution. The arrow pointing to the side from the
activated state box represents fusion between HA-contain-
ing and target membranes induced by the HA in this con-
formation. Hence, although shown for illustration in the
same scheme, this arrow indicates the transition of the
whole cell from a nonfused to a fused state. All other arrows
in Fig. 1 describe the evolution of the protein molecules,
where all transitions are assumed to be irreversible.
Let us now consider a situation where HA membrane is
prebound to the target membrane. At time t  0 the low pH
activation results in the transition of the number Na–l
0 of the
HA molecules into the activated-locked state followed by
transition into the activated-unlocked HA state and then the
inactivated state. In parallel, the membranes can fuse at any
moment t. The probability of this event depends on the
number of the HA molecules in the activated-unlocked
state. Below we describe all stages of the evolution of this
system with the following simple equations.
HA transition from the activated-locked state to the ac-
tivated-unlocked one is characterized by a time constant a–l
and is described by a kinetic equation determining the
decrease in the number Na–l of the HA molecules in the







The same assumptions were made with respect to the HA
transition from the activated-unlocked state to the inacti-
vated one; the corresponding time constant will be denoted
by a–u. The number Na–u of the protein molecules in the











FIGURE 1 Hypothetical kinetic model for HA refolding after low pH
activation leading to fusion or inactivation. (A) The normal pathway. (B)
The pathway in the presence of the fusion inhibitor. (C) The pathway after
dissociation of the HA1-receptor connection by neuraminidase. For more
details see the text.
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where the first term on the right side accounts for the
transition to the inactivated state, whereas the second one
corresponds to the number of HA molecules leaving the
activated-locked state, Na–u.
To describe the kinetics of the fusion process we have to
determine the probability Y(t) that the HA cell fuses with the
target cell in the period of time from t 0 to t. We assumed
that the fusogenic action of the HA molecules in the acti-
vated-unlocked state is determined by their number Na–u(t)
and cooperativity between them (Blumenthal et al., 1996;
Danieli et al., 1996; Ellens et al., 1990). The probability
p(t)dt that one cell fuses with the target cell within a small






where m is the number determining the cooperativity in the
action of HA molecules, and f is the time constant account-
ing for all related processes, such as the time of formation
of a multiprotein fusion machine (if needed) or the time of
a possible local rupture of a membrane monolayer required
for fusion (Leikin et al., 1987). The probability P(t)dt that a
cell will fuse within a small interval dt at a certain moment
t (i.e., it does not fuse in the period from 0 to t and then fuses





PtdtNa– um dtf (6)
Finally, the probability Y(t) that the cell fuses between t 
0 and t can be expressed by Y(t)  
0
tP(t)dt. Taking into









Solving Eqs. 3, 4, and 7, we can describe the evolution of
the system, including time-dependent changes in the num-
ber of the HA molecules in all three states represented in
Fig. 1 A, and find the probability of membrane fusion Y(t) as
a function of the time t after the low pH application.
APPROACHES TO EXPERIMENTAL
VERIFICATION OF THE MODEL
Fluorescence microscopy allows one to simultaneously ob-
serve a large number of HA cells bound to the target
membranes and to determine the percentage of cells that
underwent fusion by the time t after the low pH application
at t 0. This value is referred to as the extent of fusion. The
extent of fusion corresponding to a long enough period of
time after which no additional fusion events occur is re-
ferred to as the final extent of fusion.
Provided that all observed cells are similar, the extent of
fusion, normalized to 1 rather than to 100%, is equal to the
probability that one cell fuses, Y(t). The final extent, Yfin,
corresponds to the probability of fusion during an infinite
time of observation Yfin  Y(t  ). Hence our strategy for
the experimental verification of the model relates to the
final extent, Yfin, which is readily measurable and can be
determined theoretically. We suggest three approaches for
experimental verification of the model based on three ex-
perimental ways of influencing the evolution of the system.
Time course of inactivation in the presence of
the target membrane
Lysophosphatidylcholine (LPC) added exogenously to HA
cells with bound target membranes (e.g., RBCs) reversibly
blocks fusion at a stage that follows low pH activation of
HA but precedes the actual fusion event (Chernomordik et
al., 1997). Upon removal of LPC the fusion is allowed to
proceed. In terms of the kinetic scheme (Fig. 1), LPC blocks
the pathway leading to fusion, but not the conformational
change of HA. Thus, in the presence of LPC, the HA
molecules convert from the activated-locked to the activat-
ed-unlocked and, finally, to the inactivated state (Fig. 1 B).
The kinetic scheme returns to the initial form (Fig. 1 A)
upon LPC removal. We will use this property of LPC to
modify the time course of the system in the controlled way.
To test the model, the HA molecules will be activated by
a pulse of low pH in the presence of a fusion-inhibiting
concentration of LPC. Then LPC will be removed at a
different time t* after the end of a low pH pulse and the
resulting final extent of fusion, Yfin(t*) will be measured.
Our model gives a rather simple prediction for the character
of the function Yfin(t*). During the time t*, when fusion is
inhibited by LPC, some of the initially activated-unlocked
HA molecules undergo transition to the inactivated state,
leaving fewer HA molecules in the fusion-competent state.
Hence the probability Yfin(t*) that the cells fuse after LPC
removal should decrease with increasing t*.
The probability of fusion Yfin(t*) predicted by our model
can be determined by solving Eqs. 3, 4, and 7, taking into
account that fusion is arrested during the period of time t*.
The details of these calculations are presented in the Ap-
pendix. The main assumption allowing an analytical expres-
sion for Yfin(t*) is that the time constant a–l of the HA
transition from the activated-locked state to the activated-
unlocked state exceeds the time constant a–u of the protein
inactivation, a–l  a–u. This assumption is supported by
observations that the presence of the target membrane slows
down the kinetics of HA refolding. Hence the characteristic
time a–l of the dissociation of the HA proteins from the
target membrane has to be the longest in the hierarchy of
1418 Leikina et al.
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time constants. The resulting expression for the final extent
of fusion is
Yfint* 1
 exp a–lm  f   a– ua–l a– u
m
Na–l
0 m  exp m  t*a–l 
(8)
The predicted total extent of fusion decreases rather sharply
with increasing time t* (i.e., duration of LPC treatment),
where the dependence (Eq. 8) is double-exponential. The
major parameter determining the sharpness of this decrease
is the time constant a–l. The experimental function Yfin(t*)
will be compared with that predicted theoretically (Eq. 8).
Unlocking of the activated-locked state
Neuraminidase cleaves sialic acids at the surface of the
target membrane and disrupts the HA1-receptor connection
(Drzeniek, 1972). According to our model, such treatment
should transfer low pH-treated HA molecules directly into
the activated-unlocked state. In the kinetic scheme (Fig. 1),
the neuraminidase treatment is predicted to abolish the first
box corresponding to the activated-locked state and the
related steps in the system evolution (Fig. 1 C).
As in the previous experimental approach, we will use
LPC to block the fusion of HA cells with bound RBCs.
Immediately after the end of the low-pH application, still in
the presence of LPC, cells will be treated with neuramini-
dase, followed by LPC removal at a different time t* after
the end of the low pH pulse. Then we will measure the
resulting final extent of fusion, Yfin(t*).
The theoretical dependence of the final extent of fusion
(see Appendix) can be expressed as
Yfint* 1 exp a– um  f  Na–l0 m  exp m  t*a– u  (9)
As in the previous case, the longer t* is, the lower is the
final extent of fusion. However, neuraminidase treatment
should alter the time course of this fusion decline (Eq. 9), as
the kinetic stage characterized by the longest time constant
a–l is now excluded. As a result, the steepness of the
function Yfin(t*) is determined by the shorter characteristic
time a–u. In other words, after neuraminidase treatment the
total extent of fusion is expected to decrease as a function of
time of the fusion arrest t* faster than in the control exper-
iment. The results of this experiment will be compared with
the theoretical prediction (Eq. 9) to verify the model.
Substituting the target membrane with
soluble receptors
As previously mentioned, some strains of HA (e.g., X31
HA) rapidly inactivate at low pH in the absence of the target
membrane. Our model postulates that HA1 binding to its
receptor slows down the major refolding of the HA mole-
cule. As a third approach in the model verification, we will
test whether water-soluble sialosides inhibit HA inactiva-
tion in the absence of the target membrane.
EXPERIMENTAL METHODS
Preparing the cells for fusion experiments
HA300a cells, CHO-K1 cells expressing the X31 strain of influenza virus
HA, were grown as described by Kemble et al. (1993). Human RBCs,
freshly isolated from whole blood, were labeled with fluorescent lipid,
PKH26 (Sigma, St. Louis, MO) as done by Chernomordik et al. (1997).
HA cells were treated with 5 g/ml trypsin (Fluka, Buchs, Switzerland)
and 0.5 unit/ml neuraminidase type V Clostridium perfringens (Sigma) for
10 min at 37°C to cleave HA0 into its fusion-competent HA1-S-S-HA2
form and to improve RBC binding, respectively. Then HA cells with 0–2
bound RBC per cell were washed three times with phosphate-buffered
saline (PBS) to remove unbound RBC and then used for fusion experi-
ments. RBC binding to cells (i.e., the average number of RBCs bound to
each HA cell) was assayed for a sample of 200 cells in several different
areas of the dish. In some experiments RBC contacts with HA cells were
stabilized by cross-linking with paraformaldehyde (4% in PBS w.o. Ca,
Mg) for 20 min at room temperature.
Fusion was triggered by cell incubation with PBS titrated by citrate to
acidic pH. After low pH treatment acidic solution was replaced by PBS.
The final fusion extent was assayed by fluorescence microscopy more than
20 min after low pH application or removal of LPC as the ratio of
dye-redistributed bound RBCs to the total number of bound RBCs. Longer
incubations (up to 2 h) did not increase the extent of fusion.
In the experiments where RBC/HA cell complexes were treated by
neuraminidase there was some loss of initially bound but not fused RBCs
before the assay for fusion. This selective loss of non-fused RBCs, appar-
ently caused by the dissociation of HA1-receptor binding, resulted in an
overestimation of the fusion extent, FN. To account for it, in the experi-
ments presented in Fig. 2, A and B, we counted the percentage, PN, of
dye-redistributed HA cells among more than 1000 HA cells. Using the
found PN along with the fusion extent F0 and the percentage, P0, of labeled
HA cells in the absence of neuraminidase, we calculated the fusion extent
FN according to the relationship FN F0  PN/P0. This expression is based
on the fact that the initial binding and the numbers of RBCs and HA cells
were equal in the experiments with and without neuraminidase.
Each set of experiments for each graph presented here was repeated on
at least three occasions with similar results. Data were averaged from the
same set of experiments.
Application of exogenous lipids and
enzymatic treatments
As described by Chernomordik et al. (1997), a stock solution of lauroyl
LPC (Avanti Polar Lipids, Birmingham, AL) was freshly prepared as a
0.5% (w/w) aqueous dispersion. PBS titrated by citrate to acidic pH and
used to trigger cell fusion was also supplemented with LPC. The same
concentration of LPC was added to the neutral pH medium (PBS, pH 7.4)
used to end the low pH application.
In some experiments, HA cells with bound RBCs were treated with
neuraminidase (0.5–1 unit/ml of PBS, 5 min at room temperature) or with
thermolysin (Sigma, 0.1 mg/ml of PBS, 10 min at room temperature)
immediately after the end of the low pH application. Washing cells twice
with complete medium terminated enzymatic reactions.
In the typical experiment a pulse of low pH was applied in the presence
of a fusion-inhibiting concentration of LPC. Then, still in the presence of
Receptor Delays Hemagglutinin Refolding 1419
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LPC, but already at neutral pH, cells were treated or not with neuramini-
dase, and then, at different time points after the end of a low pH pulse, LPC
was washed out and fusion was assayed.
Functional assay for HA inactivation in the
absence of the target membrane
HA cells, pretreated with trypsin and neuraminidase as described above,
were incubated at low pH in the absence of the target membrane (referred
to as “low pH pretreatment”). Then low pH medium was replaced with pH
7.4 PBS, RBCs were added, and, 15 min later, after unbound RBCs were
washed out, a second pulse of low pH was applied to trigger fusion
(referred to as the “fusion-testing pulse”). The greater the number of HA
molecules that were inactivated during the low pH pretreatment, the lower
was the final fusion extent observed after the fusion-testing pulse. In some
experiments low pH pretreatment was preceded by a 5-min incubation of
the HA cells with sialyllactose (SL, -neu5ac-[2-3]- and -[2-6]-	-D-gal-
[1-4]-D-Glc from human milk; Sigma). We also studied the effects of two
other water-soluble glycosides, one of which, Neu5Ac alpha-benzyl gly-
coside (AG) (GlycoTech, Rockville, MD) binds to HA1, and the other of
which, Neu5Ac beta-methyl glycoside, (BG) (GlycoTech), in contrast to
alpha-anomers SL and AG, is a beta-anomer and does not bind to HA1
(Matrosovich et al., 1993; Pritchett et al., 1987; Sauter et al., 1992b).
Glycosides were dissolved in PBS and the pH was adjusted as needed.
Measuring HA activation by SDS-PAGE and
quantitative Western blot analysis
To measure the percentage of low pH-activated HA we used sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
Western blot analyses. HA300a cells, pretreated with trypsin as described
above, were acidified by pH 4.9 medium for 5 min at room temperature.
Next 20 mM dithiothreitol (DTT) was added to the cells to reduce disulfide
bonds between HA1 and HA2 subunits. This bond becomes accessible to
DTT only in the low pH-activated HA (Graves et al., 1983). Reducing this
bond releases water-soluble HA1 from membrane-anchored HA2. Cells
were lysed in 500 l of nonreducing SDS-PAGE lysis buffer (68.5 mM
Tris-HCl (pH 7.5), 2% SDS, 50 mM iodoacetamide, 5 mM EDTA, 1 mM
4-(2-aminoethyl)benzenesulfonyl fluoride, 100 M leupeptin, 100 M
3,4-dichloroisocoumarin, 10% glycerol, 0.01% bromphenol blue). Imme-
diately after lysis, samples were transferred to ice, heated to 100°C for 5
min, centrifuged at 30,000 rpm in a TLA 100.1 rotor for 30 min, and stored
at 25°C until use. Prepared lysate was analyzed by 4–12% gradient
SDS-PAGE at 10 or 15 g of total cellular protein per gel lane. Gels were
run at a constant voltage (i.e., 120 V) until the bromphenol blue front
reached the end of the gel. After proteins were blotted to Immobilon-P
filters, blots were blocked with 6% bovine serum albumin (w/v) in T-PBS
(PBS supplemented with 0.05% (v/v) Tween-20). Blots were incubated in
rabbit polyclonal serum (1500 or 12000), followed by goat anti-rabbit
(114,000) IgG conjugated with alkaline phosphatase. Dried blots were
photographed and scanned on a Molecular Dynamics scanner, using en-
hanced chemifluorescence mode. Analysis of SDS-PAGE images and
quantification of individual bands were carried out with an ImageQuant
software package (Molecular Dynamics). HA activation was presented as
a ratio of the low pH HA0 band to the pH 7.4 band.
RESULTS
Time course of inactivation in the presence of
target membrane
Under the conditions of our experiments, RBC binding to
HA cells is dependent on HA1 binding to sialic acids on the
FIGURE 2 Neuraminidase applied after HA activation modulates the time
course of the fusion inactivation at the LPC-arrested stage. (A and B) Neur-
aminidase effect on the decrease in the fusion extent observed upon LPC
removal. HA cells with bound RBCs were treated by a 5-min pulse of pH 4.9
at 22°C in the presence of 230 M lauroyl-LPC. Low pH medium was
replaced with LPC-containing PBS (pH 7.4) supplemented (B) or not supple-
mented (A) with neuraminidase (0.5 unit/ml). Five minutes later the medium
was again replaced by LPC-containing, neuraminidase-free PBS. After differ-
ent time intervals, LPC was removed by washing cells with LPC-free PBS.
Lipid mixing was measured as PKH26 redistribution from RBC to HA cells
(see Experimental Methods) 20 min after LPC removal. Each point is a
mean  SEM over 9–22 independent experiments. Solid lines represent the
theoretical curves determined by fitting the experimental data with Eqs. 8 and
9 with parameters and standard error of the fit as follows: A1 34.17 4.27,
B1  0.96  0.069 (A) and A2  13.5  2.85, B2  1.35  0.22 (B). The
norms of the residuals (square root of the sum of squares of the residuals) for
the presented fits were 13.8 and 28.9 for A and B, respectively. The meaning
of the parameters is discussed in the text. (C) Fusion inhibition by thermolysin
applied at the onset of the LPC-arrested stage. HA cells with bound RBCs
were treated with a 3-min pulse of pH 4.9 at 22°C in the presence of 230 M
lauroyl-LPC. Low pH medium was replaced with LPC-containing PBS (pH
7.4) supplemented (bar 2) or not supplemented (bar 1) with thermolysin (0.05
mg/ml). After 10 min of incubation, the medium was again replaced by
LPC-free, thermolysin-free PBS. Fusion extent was assayed as the ratio of
dye-redistributed bound RBCs to the total number of bound RBCs. The extent
of fusion (13%) observed in the experiment with no thermolysin treatment
where fusion was assayed, still in the presence of LPC, was subtracted from
both bars. Each bar is a mean  SEM, n  3.
1420 Leikina et al.
Biophysical Journal 79(3) 1415–1427
RBC surface as demonstrated by the following findings: 1)
binding is abolished for neuraminidase-treated RBCs; 2)
neuraminidase application to HA cells with bound RBCs
releases RBCs (see also Chernomordik et al., 1997), and 3)
binding is inhibited by either 20 mM SL or 5 mM AG (data
not shown).
In agreement with earlier publications (Chernomordik et
al., 1997; Melikyan et al., 1995b; Sarkar et al., 1989), low
pH application to HA cells with bound RBCs resulted in a
fast redistribution of the membrane dye PKH26 from RBCs
to HA cells. This lipid mixing (referred to below as fusion)
was observed only for HA cells, where the initial HA0 form
of HA was cleaved by trypsin into the HA1-HA2 form (not
shown).
To investigate the time course of HA inactivation in the
presence of the target membrane, one needs to block fusion.
In these experiments fusion was triggered by low pH appli-
cation in the presence of the reversible fusion inhibitor LPC.
Washing out LPC allowed fusion to ensue. The longer the
time interval between the low pH pulse and LPC wash out,
the lower the extent of fusion observed upon removal of the
fusion inhibitor (Fig. 2 A). This fusion inactivation at the
LPC-arrested stage, i.e., the transition from fusion-compe-
tent to fusion-incompetent state of HA molecules, was
rather slow. The fusion extent observed upon LPC removal
decreased from60% to20% within 45 min after the low
pH pulse.
Exposure of the fusion peptide of HA2, an early indica-
tion of a low pH-induced refolding of HA (White, 1996;
White and Wilson, 1987), apparently takes place at the very
onset of the LPC-arrested stage. A low pH pulse applied in
the presence of LPC was immediately followed by thermo-
lysin, the enzyme that cleaves the fusion peptide of HA in
the low pH conformation. Fusion inhibition observed upon
subsequent removal of LPC (Fig. 2 C) indicated that fusion
peptide exposure by low pH-activated HA molecules pre-
cedes slow inactivation of HA at the LPC-arrested stage.
Thus, if slow inactivation of fusion at the LPC-arrested
stage reflects unlocking of the activated-locked state as
suggested by our model, this state follows fusion peptide
exposure to thermolysin-accessible conformation.
Dissociation of HA1-receptor binding by
neuraminidase as an attempt to unlock the
activated-locked state of HA
Neuraminidase treatment of the cells at the LPC-arrested
stage caused a notable change in the pattern of the inacti-
vation (Fig. 2 B). In these experiments HA cells were
incubated with neuraminidase for 5 min immediately after
the end of low pH pulse in the LPC-containing medium. As
HA cells were already pretreated with neuraminidase before
the addition of RBCs (see Experimental Methods), the en-
zyme application at the LPC-arrested stage is mainly in-
tended to remove the sialic acids from the surface of bound
RBCs. Note that RBCs remain bound to HA cells even after
neuraminidase treatment because of an additional low-pH-
dependent binding apparently mediated by fusion peptide
insertion into the RBC membranes (Chernomordik et al.,
1997; Tsurudome et al., 1992). In the experiment presented
in Fig. 2 B, neuraminidase treatment of the cells at the
LPC-arrested stage was followed by LPC removal at differ-
ent time points and then assaying the fusion extent. Washing
LPC out immediately after neuraminidase treatment results
in a higher fusion extent than that in the experiment with no
neuraminidase treatment (see Fig. 2, A and B). A similar rise
in the fusion extent (1.3  0.1 (mean  SD, n  19)) was
observed in the experiments where low pH pulse (pH 5, 5
min, 22°C) was applied in the absence of LPC and was
immediately followed by neuraminidase treatment. Promo-
tion of fusion by neuraminidase treatment right after the low
pH application is consistent with our hypothesis. However,
alternative interpretations such as cleaning of the membrane
surfaces by enzymes cannot be excluded (Melikyan et al.,
1995a).
In all of these experiments, the concentration of LPC that
almost completely suppressed fusion was chosen. On the
other hand, treatment with neuraminidase in the presence of
the same LPC concentration resulted in significant fusion.
To suppress fusion in these conditions we had to further
increase the concentration of LPC. For instance, in a pre-
liminary experiment the extent of fusion in the presence of
170 M LPC was 58% and 6.7% with and without neur-
aminidase treatment, respectively. At an increased LPC
concentration of 230 M, the fusion extent observed with
and without neuraminidase treatment was 3.4% and 0%,
respectively. This is an additional indication of the fusion
promotion by the neuraminidase.
Neuraminidase-induced promotion of HA-mediated fu-
sion was transient. The decrease in fusion with time at the
LPC-arrested stage was significantly faster after the neur-
aminidase treatment than in the control conditions (Fig. 2
A). These findings are consistent with our model suggesting
that HA1-receptor interactions inhibit the inactivation of
HA. Alternatively, these interactions can be important for
directing HA refolding to a fusion-competent conformation
rather than for slowing down subsequent inactivation of
HA.
While RBCs remain bound to HA cells after neuramini-
dase treatment, fast fusion inactivation can be explained by
the loss in “quality” of cell contacts. For instance, breaking
the HA1-sialic acid connection between cells might inhibit
fusion by weakening and decreasing the area of the contact.
To test this possibility, we stabilized the contact between
HA cells and RBCs by mild cross-linking with paraformal-
dehyde. Paraformaldehyde was applied to HA cells with
bound RBCs before low pH application. After paraformal-
dehyde cross-linking, cell binding became independent of
the HA1-sialic acid connection, as evidenced by the lack of
RBC release upon neuraminidase treatment of the cells.
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Importantly, the cross-linking did not decrease the final
extent of low pH-triggered fusion mediated by HA. HA
cells with bound and cross-linked RBCs were treated with a
low pH pulse followed by neuraminidase in the presence of
LPC. The rate of fusion inactivation for cross-linked cells
was significantly decreased, and we were not able to detect
any difference between the rates of inactivation for HA
cell/RBC complexes treated versus untreated with neur-
aminidase. We suggest that under these conditions the ki-
netics of HA inactivation is not limited by the release of
HA1-receptor connections. However, as for non-cross-
linked cells, the neuraminidase treatment of cross-linked
cells after low pH application promoted fusion (data not
shown). These results argue against the role of cell binding
changes in the inactivation of fusion.
Our hypothesis that the HA1-receptor connection has to
be disrupted before a major conformational change in HA
was indirectly substantiated by measuring the effect of low
pH application on RBC binding to HA cells. RBC binding
to HA300a cells pretreated with pH 4.9 before the addition
of RBCs was significantly lower than that in the absence of
the low pH pretreatment (Fig. 3). Thus at later stages of low
pH-induced conformational change HA loses its ability to
bind to membrane-anchored receptor, suggesting that the
energy released during HA refolding should compensate for
the lost energy of binding between HA1 and receptor. These
data indicate the irreversibility of the transition between the
receptor-bound initial state of HA and its final inactivated
unbound state. Thus this transition has to be described by an
irreversible, one-way kinetic scheme, such as the one sug-
gested in Fig. 1, rather than by an equilibrium partitioning
of HA between different states.
Water-soluble sialosides inhibit HA inactivation in
the absence of the target membrane
As reported earlier for X31 HA (Puri et al., 1990), short-
term acidification of the X31 HA-expressing HA300a cells
in the absence of RBCs (referred to as low pH pretreatment)
caused profound inactivation of HA (Fig. 4 A). After a
5-min-long pretreatment with pH 4.9, HA lost most of its
ability to mediate fusion with the subsequent addition of
RBCs, followed by a second, fusion-testing low pH pulse
(see Experimental Methods). This inactivation of HA in the
absence of the target membrane was inhibited by SL (Fig. 4
A). In these experiments, HA300a cells were incubated with
20 mM SL for 10 min and then treated with pH 4.9 for 5
min. After replacing acidic medium with SL-free PBS (pH
7.4), we added RBCs, applied the fusion-testing pulse, and
assayed for fusion. As the final extent of fusion observed in
this experiment was higher than that in the control (no SL),
we concluded that SL lowers the rate of inactivation in the
absence of the target membrane. Another soluble sialoside,
AG, which binds to HA1 with even higher affinity than SL,
also protects HA against inactivation in the absence of the
target membrane (Fig. 4 B). Note that AG inhibited inacti-
vation at a significantly lower concentration than SL. This
difference can be explained by the known 5–10-fold in-
crease in the affinity of this sialoside for HA1 upon replace-
ment of the methylic aglycon with the benzylic one (Ma-
trosovich et al., 1993). In addition, SL from human milk
used in this study contains mostly 2–6 isomer of SL, which
has a lower affinity for X31 HA than 2–3 isomer (Matroso-
vich et al., 1993; Sauter et al., 1992b). We compared the
effects of SL and AG with that of BG, beta-anomer meth-
ylglycoside, which does not bind to HA1 (Matrosovich et
al., 1993; Pritchett et al., 1987; Sauter et al., 1992b). As
expected, BG did not affect the rate of HA inactivation (Fig.
4 C) and RBC binding to HA cells (data not shown). In
contrast to SL and AG, BG did not affect HA inactivation,
suggesting that inhibition of HA inactivation by SL and AG
involves their binding to HA1. Thus sialic acid-containing
molecules inhibited inactivation of HA when present either
at the surface of the target membrane (Fig. 2, A and B) or in
a water-soluble form (Fig. 4).
One may hypothesize that soluble receptors inhibit the
activation of HA rather than its further refolding, which was
assayed above as HA inactivation. To exclude this possi-
bility, we evaluated the percentage of activated HA as the
percentage of HA molecules with the DTT-accessible di-
sulfide bond stabilizing the HA1-HA2 complex. Because
release of HA1 in the presence of DTT is an irreversible
event, all low pH-activated HA are assumed to lose their
HA1 subunit during a 20-min incubation with DTT. This
low pH-triggered and DTT-induced loss of HA1 can be
readily detected by immunoblotting with antibodies against
HA1 (Fig. 4 D). As reported earlier (Puri et al., 1990), a
5-min application of pH 4.9 to HA cells in the absence of
FIGURE 3 Pretreatment of HA cells with pH 4.9 medium inhibits sub-
sequent binding of RBCs. In this representative experiment, HA cells were
incubated at pH 4.9 (22°C) for different time intervals, then low pH
medium was replaced with PBS (pH 7.4) supplemented with RBCs. After
15 min of incubation, followed by the removal of unbound RBC with five
washings with PBS, binding was assayed by counting RBCs bound to more
than 200 HA cells.
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RBC activated a significant part of HA molecules. The
percentage of activated HA was not affected by SL. This
finding, along with the functional data in Fig. 4, A–C,
suggested that a soluble receptor of HA1 slows down the
refolding of already activated HA.
DISCUSSION
Influenza virus entry into a host cell starts with specific
binding between HA1 at the viral envelope and sialic acids
at the cell surface. In the present work we tested the possi-
bility that this binding restricts low pH-induced conforma-
tional changes in HA and resulting membrane fusion. The
dissociation of the HA-receptor bonds was hypothesized to
constitute a slow stage in HA refolding, leading to the
fusion-competent conformation. This hypothesis explains
the earlier finding that inactivation of HA-expressing mem-
brane with respect to fusion is slower in the presence of the
target membrane.
To verify this hypothesis we first formulated a simple
kinetic scheme that allowed us to analyze the probability
that an HA cell fuses with its target membrane. This prob-
ability is equal to the fusion extent measured experimen-
tally. HA evolution in our scheme starts with a low pH
activation. This early conformational change in HA can be
detected as an exposure of the fusion peptide by specific
antibodies (White and Wilson, 1987) and enzymes such as
thermolysin (Wiley and Skehel, 1987). For receptor-bound
HA, the activated-locked state and then the activated-un-
locked state follow this early conformational change. In the
absence of the receptors, however, the activated-locked
state is omitted.
The predictions of the hypothesis on the role of the
HA1-receptor connections were verified by measuring fu-
sion inactivation in time at the LPC-arrested stage. The
corresponding theoretical dependence of the final extent of
fusion Yfin on the time interval t* between low pH applica-
tion and LPC removal is given by Eq. 8. We also studied the
FIGURE 4 Fusion inactivation (A and B) and HA
activation (C) in the presence of soluble glycosides.
(A) HA cells were incubated at pH 4.9 for 5 min at
37°C with (3) or without (2) 20 mM SL. Then low pH
medium was replaced with PBS (pH 7.4) supple-
mented with RBCs. After 15 min of incubation, fol-
lowed by wash-out of unbound RBCs, a second low
pH pulse (pH 5.5, 5 min, 37°C) was applied. The
fusion extent was assayed as the ratio of dye-redistrib-
uted bound RBCs to the total number of bound RBCs.
The fusion extent observed in the experiment, where
the first low pH pulse (pretreatment of HA cells; Puri
et al., 1990) was skipped, is represented by bar 3. Each
bar is a mean SEM, n 3. (B and C) HA cells were
treated by pH 4.9 for 2 min at 22°C in the presence of
0, 1.6, 4, or 8 mM AG (B, bars 1–4, respectively), or
0, 5, or 20 mM BG (C, bars 1, 2, 3, respectively).
Then low pH medium was replaced with glycoside-
free PBS (pH 7.4) supplemented with RBCs. After 15
min of incubation, followed by washing out of un-
bound RBCs, a second low pH pulse (pH 4.9, 1 min,
22°C) was applied. The fusion extent was assayed as
the ratio of dye-redistributed bound RBCs to the total
number of bound RBCs. The fusion extent observed in
the experiment, where low pH pretreatment of HA
cells in the absence of the target membrane was
skipped, is represented by bars 5 (B) and 4 (C) for the
experiments shown in B and C, respectively. Each bar
is a mean SEM, n 3. (D) HA cells were incubated
at pH 4.9 for 5 min at 37°C with (3) or without (2) 20
mM SL. Then cells were lysed, and the percentage of
the activated HA (defined as HA molecules with DTT-
accessible S-S bond between HA1 and HA2 subunits;
Graves et al., 1983) was measured as described in
Experimental Methods.
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time course of the fusion inactivation after neuraminidase
application at the LPC-arrested stage. Neuraminidase re-
leases water-soluble sialic acid from the HA receptors at the
surface of RBC and thus causes rapid dissociation of the
HA1-receptor bonds. These experimental conditions are
described by the theoretical dependence in Eq. 9.
Our experimental findings are consistent with the predic-
tions of the hypothesis. Breaking the HA1-receptor bonds
by neuraminidase appears to temporarily boost the number
of fusion-competent HAs, as indicated by an increase in
fusion in the experiments where LPC block was lifted
immediately after neuraminidase treatment. As predicted,
this increase is only transient, and the rate of fusion inacti-
vation after neuraminidase treatment is significantly higher
than in the control (Fig. 2, A and B). We fitted two data sets
obtained in the representative experiment (with and without
neuraminidase) with the theoretical equations (Eqs. 8 and
9), which can be presented in a common form, Y(t)  1 
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To decrease the number of fitting parameters we assumed
that the number m characterizing the cooperativity of fuso-
genic action of the activated HA molecules was equal to
m  3 (Danieli et al., 1996). We have chosen this estimate
rather than the estimate of m  6 suggested by Blumenthal
et al. (1996), who based their analysis on fusion pore
formation, whereas we and Danieli et al. (1996) assayed
fusion as lipid mixing. Lipid mixing could involve fewer
HA molecules than necessary for fusion pore opening
(Chernomordik et al., 1998). Note that the choice of the
specific value of m does not change the quality of the fit but
does affect the obtained characteristic times.
To fit Eqs. 8 and 9 to the experimental data, taking into
account the relationship between B1/B2 and A1/A2 (see
above), we used the standard SigmaPlot software minimiz-
ing the mean square deviation with respect to two indepen-
dent fitting parameters, A and B. While the constraints
drastically reduced the number of fitting solutions and, thus,
did not allow us to reach a better fitting, the model does
provide a reasonable qualitative description of the experi-
mental points. The kinetic parameters found from the fitting
are A1 34 min, A2 13.5 min, B1 0.96, and B2 1.35.
The time constants of the HA transition from the activated-
locked state to the activated-unlocked state a–l and from the
activated-unlocked state to the inactivated state a–u are
a–l  102 min and a–u  41 min, respectively. The found
values of the characteristic times satisfied the assumption of
the model that a–l/a–u  1.
The estimated value of a–u is significantly longer than
the duration of low pH pretreatment of X31 HA-express-
ing membrane, which results in complete loss of its ability
to fuse (10 min; see above and Puri et al., 1990). We
suggest that this difference reflects the cooperativity of
HA-mediated fusion: the probability of fusion is a nonlinear
function of the membrane concentration of fusion-compe-
tent HA, and, therefore, fusion becomes improbable already
at early stages of HA inactivation. The time constant of the
transition from the activated-unlocked state to the inacti-
vated state a–u  41 min is close to the half-time of
exposure of the interface between HA1 monomers in a
trimer ( 50 min) observed at 25°C for HA ectodomain in
the absence of any membranes and receptors (White and
Wilson, 1987). One may hypothesize that HA inactivation
beyond the activated-unlocked state involves dissociation of
the globular head HA1 domains.
The time constant of transition of HA molecules from the
activated-locked to the activated-unlocked state, a–l, is es-
timated as 102 min. At present, we have no independent
way to verify how reasonable this value is. We hope that
future experiments with conformation-specific antibodies
will allow a direct measurement of the time course of
structural changes of HA from the hypothetical activated-
locked state to inactivated state. Equations A1 and A5 in the
Appendix give a prediction for this evolution. One may ask
whether this result is consistent with the rather fast kinetics
of HA-mediated fusion. In our model the release of HA
from the activated-locked state has a continuous character:
the probability that each HA is unlocked increases expo-
nentially with time. Therefore, for a sufficiently high total
number of activated HAs in each cell, even in the first
minute there are enough unlocked HA molecules to mediate
fusion in some of the cells observed. According to Danieli
et al. (1996), fusion of HAb2 cells with RBC reaches 9%
of the maximum extent within 1 min after low pH applica-
tion at 29°C. The estimate based on our model with the
parameters presented above gives 3% of fusion within 1
min. We consider this agreement to be satisfactory, taking
into account the difference in cell lines (HAb2 vs. HA300a)
and temperatures (29°C versus 22°C) and other differences
in the experimental protocols.
One may think that the HA1-receptor connection slows
down the HA refolding because of mechanical constraints.
Fusion requires sideways relocation of the globular subunits
of HA1 from the top of HA molecule (Godley et al., 1992;
Kemble et al., 1992). In the case of HA1 bound to mem-
brane-anchored receptor, such a relocation should be hin-
dered by the required deformation of either membranes or
proteins. Alternatively, the HA-receptor connection may
inhibit the lateral mobility of HA molecules required for
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their assembly into functional or inactivated complexes
(Alford et al., 1994; Gutman et al., 1993). However, water-
soluble receptors, SL and AG, also slowed down HA inac-
tivation. This finding suggests that just the presence of the
receptor in the binding site of HA1 inhibits the completion
of HA conformational change. Strikingly similar phenom-
ena were reported for other proteins. Binding of the B
subunit of cholera toxin to sialic acid in a ganglioside
receptor does not prevent a conformational change upon
low pH application, but stabilizes the structure of the B
subunit against denaturation and collapse at low pH (Mc-
Cann et al., 1997). Transition of an enveloped glycoprotein
from Rous sarcoma virus to a membrane-binding confor-
mation is associated with the release of a cellular receptor of
the protein (Damico et al., 1998).
One of the insights from our work is that while the
dissociation constant for the interaction of soluble HA1 and
sialic acid appears to be rather high, all HAs that are close
enough to the receptor-expressing target membrane should
be bound because of the very high membrane concentration
of the proteins under these conditions. Note that if one of the
interacting molecules is present in a water-soluble form, as
in our experiment with SL, its concentration required to
achieve considerable binding should be above the dissoci-
ation constant Kd 3 mM (Sauter et al., 1992b). At a lower
concentration of SL, such as the one used by Stegmann et al.
(1995) (less than 0.1 mM, as estimated from the data pre-
sented there), the percentage of bound HA is expected to be
very low.
Our model is clearly oversimplified and neglects a num-
ber of known and important features of the system, such as
any effects of receptors at the earlier stages of HA refolding
(de Lima et al., 1995; Stegmann et al., 1995) and the
existence on HA1 of two different types of receptor-binding
sites (Sauter et al., 1992a). In addition, our kinetic scheme
does not account for known substeps of the fusion reaction
and does not suggest a specific structure for any of the
states.
Both conformational change in HA and membrane fusion
are known to involve a number of distinct stages (Blumen-
thal et al., 1991; Chernomordik et al., 1998; Melikyan et al.,
1997; White, 1996; Zimmerberg et al., 1994). This work
proposes a new stage: unlocking of the HA1-receptor con-
nection, with a yet undefined place within the fusion path-
way. We know that this stage follows an early low pH-
induced activation of HA, such as exposure of the HA
fusion peptide, and precedes a major refolding of HA lead-
ing to fusion or inactivation. We hypothesize that activated
HA molecules can build up functional fusion complexes
while still being locked. This would prevent the premature
inactivation of HA and thus increase fusion efficiency. If
this is correct, the unlocking stage has a clear biological
relevance. Alternatively, slowing down the major refolding
of HA by the HA1-receptor connection may allow more
time for the fusion peptide insertion into the right membrane
and in the right orientation. The well-timed release of con-
nections between HA1 and receptor molecules would also
facilitate the final expansion of a fusion pore. The hypo-
thetical contribution of unlocking of the HA1-receptor con-
nection in the time course of the fusion reaction suggests a
new role for viral neuraminidase. Cleaving of the viral
receptors after acidification of the endosome content can
facilitate a major conformational change in unlocked HA
molecules. Interactions between some fusion proteins (e.g.,
HIV gp120) and their membrane receptors play an impor-
tant role in fusion protein activation (Dimitrov, 1997). This
study proposes an additional mechanism by which a recep-
tor can control the time course of protein refolding to a
fusion-competent conformation.
APPENDIX: SOLUTION OF THE
KINETIC EQUATIONS
We should first consider the conditions corresponding to our experimental
protocol, where a low pH pulse is applied at the moment t  0 in the
presence of LPC. Then, after a time interval t*, LPC is removed and fusion
is allowed to proceed. The time evolution of the number Na–u of HA
molecules in the activated-unlocked state as determined by solution of Eqs.





0  exp ta–l exp ta– u
(A1)
We insert Eq. A1 into Eq. 7, assuming that a–l  a–u (see the text) and,
therefore, neglecting the second contribution in Eq. A1. Solution of Eq. 7
provides us with an expression for the time dependence of the probability
of fusion,
Yt 1
 B  exp a–lm  f   a– ua–l a– u
m
 Na–l
0 m  exp m  ta–l 
(A2)
where B is an integration constant. According to the experimental setup, no
fusion occurs before t*. This means that the probability of fusion Y(t) is
meaningful only for t  t* and satisfies the condition Y(t*)  0. Using this
condition, we find B, and the resulting probability of fusion is presented by
Yt 1 exp a–lm  f   a– ua–l a– u
m
 Na–l
0 mexp m  ta–l 
 exp m  t*a–l  (A3)
Equation A3 shows that the probability of fusion increases with the time of
observation t. The maximum probability of fusion corresponding to the
final extent of fusion measured experimentally is reached for a sufficiently
long time t 3  and is presented by Eq. 8.
Now let us consider the conditions of the experimental protocol, where
low pH pulse activating the HA molecules in the presence of LPC was
followed, still in the presence of LPC, by neuraminidase treatment. We
assumed that Na–l
0 of the HA molecules are transferred directly to the
activated state and no HA resides in the activated-locked state. In this case
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the time evolution of the number Na–u of the activated HA molecules is







and is equal to
Na– u Na–l
0  exp ta– u (A5)
By inserting Eq. A5 into Eq. 7, we can solve the latter equation, account-
ing, as above, for the boundary condition Y(t*)  0. The resulting expres-
sion for the time dependence of the probability of fusion beginning from
the time t* is given by
Yt 1 exp a– um  f  Na–l0 mexp m  ta– u
 exp m  t*a– u  (A6)
The probability of fusion corresponding to a long enough experimental
time, t 3 , and representing the total extent of fusion is given by Eq. 9.
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